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1.1. A library of Hsp90 inhibitors
Heat shock protein 90 (Hsp90) is an ATP-dependent protein
that maintains the stability of client proteins by a chaperone
mechanism. Hsp90 is recognised as an important anti-cancer tar-
get as many of the proteins it chaperones can be overexpressed
in tumour cells. Through inhibition of Hsp90, these proteins are
released for degradation leading in some cases to apoptosis.
Many proteins have a role in cell survival and growth, and the
maintained up-regulation of Her2, cKit, MET and the androgen
receptor by Hsp90, reinforces its importance as an anti-cancer
target.
Many compounds that bind into the ATP-recognition cleft in
Hsp90, including the natural product geldanamycin, have been
investigated as anticancer therapies. One particular class that has
been explored is the family of resorcinol derivatives such as PD-
180854 (1). These compounds have limitations however, as the
resorcinol phenolic groups are readily glucuronidated, increasing
the hydrophilicity of the compounds and accelerating their renal
clearance. A recent publication describes the parallel synthesis of
resorcinol amides that are potent Hsp90 inhibitors and that also
have reduced clearance by glucuronidation.1
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As glucuronidation by UDP-glucuronosyl transferase (UGT) is
driven by the lipophilicity of the substrate compounds, the li-
brary compounds were designed to reduce potential clearance
by incorporation of a basic amine. Indeed compound 2 which
possessed a Ki value of 9.1 nM represented the prototype for
this library approach although this compound had only modestdoi:10.1016/j.comche.2009.10.001
E-mail: nterrett@ensemblediscovery.comcellular activity. The paper describes the synthesis of a reductive
amination library (3) where the amine substituent was placed in
the para- or meta- positions of a 2-arylpyrrolidine ring. A sub-
sequent library (4) was designed with the goal of exploring pos-
sible alternatives to the resorcinol ring by the introduction of 14
different heterocycles which were further substituted by OH, SH
or NH2 groups.
N
OOH
HO
Cl 3
NRR
A
A
A
A
N
OXH Ar
4
The library 3 of 2  89 compounds was prepared in solution,
and gave 131 puriﬁed compounds from which were identiﬁed
three racemic Hsp90 inhibitors. Resolution of the racemates by chi-
ral SFC gave one homochiral compound with 27 nM potency for
AKT degradation in H1299 cells: a level of potency some ten-fold
above the lead compound 2.1.2. Combinatorial approach to agonists of estrogen-related receptor c
Nuclear receptors are central to the activation of gene tran-
scription resulting in embryonic development, growth and differ-
entiation. Naturally-occurring ligands for nuclear receptors
include steroids, vitamin D and bile acids, and as a class tend to
be hydrophobic and lipid-soluble. Amongst the nuclear receptors
are a group of orphan receptors termed the estrogen-related
receptors (ERRs) which have been divided into three isoforms:
ERRs a, b and c. Although they are very similar and show struc-
tural homology to the estrogen receptors, the ERRs do not bind
estrogen.
ERRc is the newest of the family to be identiﬁed, and is highly
expressed in brain, skeletal muscle, heart, kidney, pancreas and
placenta. Although very little is known about the function of the
receptor, ERRc-positive status in human breast cancer could sug-
gest a favourable prognosis. With a role in cancer and possibly
metabolic disease, there is a probable role for synthetic agonists.
4-Hydroxytamoxifen (4-OHT) and diethylstilbestrol have been re-
ported to be inverse agonists for ERRc and this has initiated a study
of novel and selective ligands.2
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In this recent publication, the authors describe how they ana-
lysed the proﬁles of published ligands of ERRc, and compared the
X-ray crystal structures of ERRc ligand binding domains co-crystal-
lised with 4-OHT and the synthetic agonist, GSK 4716 (5). Through
this analysis it was concluded that the selectivity of GSK 4716
could be improved by the introduction of selectivity elements in
a region of the protein labelled pocket B, as well as by inserting
groups into pocket A to pick up an interaction with an aspartic acid
residue.
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Based on this plan and the structure of GSK 4716, a 30-member
library of acyl hydrazones (6) was synthesised using a microwave-
assisted solution-phase method. The reactions, undertaken in
n-butanol, proceeded to give products in excellent yields and puri-
ties, and these were characterised by NMR and mass spectrometry.
Many of the compounds screened at 1 lm showed activity similar
to GSK 4716, and in particular, one compound (7) signiﬁcantly
enhanced the transcriptional activity of ERRc in the cell-based
reporter gene assay.
2. A summary of the papers in this month’s issue
2.1. Solid-phase synthesis
The compatibility of Oxyma-based uronium-type coupling re-
agent COMU with microwave-assisted peptide synthesisers has
been demonstrated. COMU displayed higher efﬁciency than benzo-
triazole classical immonium salts HATU and HBTU in the demand-
ing solid-phase synthesis of the Aib derivative of Leu-enkephalin
pentapeptide and did not yield Oxyma-based by-products.3
Imidazolium triﬂuoroacetate has been used as a replacement
for tetrazole in the efﬁcient synthesis of phosphotyrosine. This
modiﬁcation is compatible with the protecting groups commonly
used in Fmoc-solid phase peptide and solution-phase synthesis.4
The solid-phase synthesis of a library based on an unusual
biphenyl-containing trypsin-like serine protease inhibitor has been
described. Key to this effort was the synthesis of a highly function-
alised aryl boronic acid reagent which required the development of
a novel and efﬁcient method to convert a triﬂate to a pinacolboro-
nate on a large scale.5
2.2. Solution-phase synthesis
The stereoselective synthesis of ten unique bifunctional adja-
cent bis-THF intermediates has been described. The key steps usedin the synthesis of these compounds included the rhenium(VII)
oxide-mediated and the Co(modp)2-catalysed trans oxidative
cyclisations, the OsO4-catalysed cis oxidative cyclisation, and the
Williamson’s type etheriﬁcation reactions.6
A library of 72 quinolones has been synthesised from substi-
tuted anthranilic acids, using ynone intermediates. These masked
b-dicarbonyl synthons allowed cyclisation under milder conditions
than previously reported quinolone syntheses.7
A convenient chemoenzymatic strategy for synthesising sialo-
sides containing a C5-diversiﬁed sialic acid has been developed.
The a2,3- and a2,6-linked sialosides containing a 5-azido neuram-
inic acid were synthesised by a highly efﬁcient one-pot three-en-
zyme approach. They were converted to C500-amino sialosides,
which were used as common intermediates for chemical parallel
synthesis to quickly generate a series of sialosides containing var-
ious sialic acid forms.8
2.3. Scaffolds and synthons for combinatorial libraries
A convenient, regioselective synthesis of the novel 1-tert-butyl-
4-nitro-1H-pyrrole-3-carboxylic acid building block has been
developed, using the bulky tert-butyl moiety of 1-tert-butyl-1H-
pyrrole to direct selective, unsymmetrical substitutions to the
desired 3 and 4 positions.9
2.4. Solid-phase supported reagents
A polymer-supported palladium(0) diphenylphosphinoethane
complex has been found to be a highly active catalyst for the cop-
per-free Sonogashira coupling reaction of aryl iodides with termi-
nal alkynes, giving excellent yields of products (85–98%) under
aerobic conditions.10
2-Phenylseleno aldehydes and ketones have been selectively
obtained using a solid-supported catalyst (KF/Al2O3) and PEG-400
as clean, recyclable medium in good to excellent yields. The
method was applied in the preparation of highly functionalised
2-phenylseleno citronellal and citronellol, which are potential
bactericide agents.11
2.5. Novel resins, linkers and techniques
A dynamic combinatorial library has been generated under
thermodynamic control by using the aminocarbonyl/imine inter-
conversion as reversible chemistry, combined with non-covalent
binding within the active site of the metalloenzyme human car-
bonic anhydrase II (hCA II). The high afﬁnity of hCA II isozyme to-
wards some sulphonamide inhibitors obtained here was used to
select from the dynamic library speciﬁc inhibitors of this isoform.12
2.6. Library applications
The synthesis and biological evaluation of a focussed library of
N-alpha mercaptoamide containing dipeptides as inhibitors of the
zinc metallopeptidase Pseudomonas aeruginosa elastase (LasB) has
been reported. The aim of the study was to derive an inhibitor pro-
ﬁle for LasB with regard to mapping the S10 binding site of the en-
zyme. Consequently, a focussed library of 160 members was
synthesised, using standard Fmoc-solid phase methods.13
The synthesis and biological activity of a library of aminoalco-
hol-derived macrocycles has been described. From this library,
robotnikinin, a binder to and inhibitor of Sonic Hedgehog, was de-
rived. Compounds were synthesised using an asymmetric alkyl-
ation to set a key stereocentre and an RCM reaction to close the
macrocycle. Follow-up chemistry led to a library of macrocycles
with enhanced biological activity relative to the original hit
compounds.14
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brary of ﬂavan-3-ol derivatives on a1b2c2L GABAA receptors has
been reported. Structure–activity relationships of various substitu-
ents on the A, B and C rings were evaluated in a functional electro-
physiological assay. A trans conﬁguration and a 3-acetoxy moiety
are essential for activity, whereas substitution of the B ring appears
to be well tolerated, with substituents on the A ring playing a ma-
jor role in determining activity.15
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